🇺🇸 FDA
Patent

US 7622123

Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines

granted A61KA61K2039/5254A61K2039/5256

Quick answer

US patent 7622123 (Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Nov 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Nov 24 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
36
CPC classes
A61K, A61K2039/5254, A61K2039/5256, A61K2039/543, A61K2039/544